S
Sofiane Fodil
Researcher at University of Paris
Publications - 12
Citations - 903
Sofiane Fodil is an academic researcher from University of Paris. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 5, co-authored 6 publications receiving 463 citations.
Papers
More filters
Journal ArticleDOI
The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection.
TL;DR: In this article, the role of endothelial cells (ECs) in vascular dysfunction, immunothrombosis, and inflammation in severe SARS-CoV-2 infections has been emphasized.
Journal ArticleDOI
Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19.
Alexandre Alanio,Alexandre Alanio,Sarah Dellière,Sarah Dellière,Sofiane Fodil,Stéphane Bretagne,Stéphane Bretagne,Bruno Mégarbane +7 more
Journal ArticleDOI
Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort
Sarah Dellière,Sarah Dellière,Emmanuel Dudoignon,Sofiane Fodil,Sebastian Voicu,Magalie Collet,Pierre-Antoine Oillic,Maud Salmona,François Dépret,François Dépret,Théo Ghelfenstein-Ferreira,Benoit Plaud,Benjamin G. Chousterman,Stéphane Bretagne,Stéphane Bretagne,Elie Azoulay,Alexandre Mebazaa,Alexandre Mebazaa,Bruno Mégarbane,Alexandre Alanio,Alexandre Alanio +20 more
TL;DR: IPA is a relatively frequent complication in severe COVID-19 patients responsible for increased mortality and Azithromycin, known to have immunomodulatory properties, may contribute to increase CO VID-19 patient susceptibility to IPA.
Journal ArticleDOI
Combination of Mycological Criteria: a Better Surrogate to Identify COVID-19-Associated Pulmonary Aspergillosis Patients and Evaluate Prognosis?
Sarah Dellière,Emmanuel Dudoignon,Sebastian Voicu,Magalie Collet,Sofiane Fodil,Benoit Plaud,Benjamin G. Chousterman,Stéphane Bretagne,Elie Azoulay,Alexandre Mebazaa,François Dépret,Bruno Mégarbane,Alexandre Alanio +12 more
TL;DR: A combination of markers and/or blood biomarkers and/ or direct respiratory sample examination seems more likely to identify patients with CAPA.
Journal ArticleDOI
High Prevalence of Putative Invasive Pulmonary Aspergillosis in Critically Ill COVID-19 Patients
TL;DR: It is strongly convinced that testing deep lung specimens for Aspergillus in severe COVID-19 patients should be recommended and tested for fungal secondary pneumonia and antifungal prophylactic therapy may be questioned to avoid increased lung inflammation that may compromise the outcome.